Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer “Revision” value was updated from v3.5.2 to v3.5.3, reflecting a change in the website’s release/version without altering the underlying clinical study information.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Carcinoma of esophagus as a condition term. Added a Resources link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check56 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 as part of the site's versioning updates.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.4.3 was added in the revision history and Revision: v3.4.2 was removed. No impact on the study’s data or page usability.SummaryDifference0.1%

- Check92 days agoChange Detected- Revision updated from v3.4.1 to v3.4.2; a minor version change with no impact on study content or usability. - To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.